Literature DB >> 20400636

Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury.

Youngnam Cho1, Riyi Shi, Richard B Borgens.   

Abstract

Chitosan, a non-toxic biodegradable polycationic polymer with low immunogenicity, has been extensively investigated in various biomedical applications. In this work, chitosan has been demonstrated to seal compromised nerve cell membranes thus serving as a potent neuroprotector following acute spinal cord trauma. Topical application of chitosan after complete transection or compression of the guinea pig spinal cord facilitated sealing of neuronal membranes in ex vivo tests, and restored the conduction of nerve impulses through the length of spinal cords in vivo, using somatosensory evoked potential recordings. Moreover, chitosan preferentially targeted damaged tissues, served as a suppressor of reactive oxygen species (free radical) generation, and the resultant lipid peroxidation of membranes, as shown in ex vivo spinal cord samples. These findings suggest a novel medical approach to reduce the catastrophic loss of behavior after acute spinal cord and brain injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400636     DOI: 10.1242/jeb.035162

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  30 in total

1.  Assessment of white matter loss using bond-selective photoacoustic imaging in a rat model of contusive spinal cord injury.

Authors:  Wei Wu; Pu Wang; Ji-Xin Cheng; Xiao-Ming Xu
Journal:  J Neurotrauma       Date:  2014-09-26       Impact factor: 5.269

Review 2.  Recent advances in nanotherapeutic strategies for spinal cord injury repair.

Authors:  Young Hye Song; Nikunj K Agrawal; Jonathan M Griffin; Christine E Schmidt
Journal:  Adv Drug Deliv Rev       Date:  2018-12-22       Impact factor: 15.470

3.  Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord.

Authors:  Wei Wu; Seung-Young Lee; Xiangbing Wu; Jacqueline Y Tyler; He Wang; Zheng Ouyang; Kinam Park; Xiao-Ming Xu; Ji-Xin Cheng
Journal:  Biomaterials       Date:  2013-12-12       Impact factor: 12.479

4.  Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury.

Authors:  Mahasweta Das; Chunyan Wang; Raminder Bedi; Shyam S Mohapatra; Subhra Mohapatra
Journal:  Nanomedicine       Date:  2014-01-29       Impact factor: 5.307

5.  Bone marrow stromal cells-loaded chitosan conduits promote repair of complete transection injury in rat spinal cord.

Authors:  Xue Chen; Yang Yang; Jian Yao; Weiwei Lin; Yi Li; Ying Chen; Yilu Gao; Yumin Yang; Xiaosong Gu; Xiaodong Wang
Journal:  J Mater Sci Mater Med       Date:  2011-07-28       Impact factor: 3.896

6.  Enhanced Neuroprotection of Acetyl-11-Keto-β-Boswellic Acid (AKBA)-Loaded O-Carboxymethyl Chitosan Nanoparticles Through Antioxidant and Anti-Inflammatory Pathways.

Authors:  Yi Ding; Youbei Qiao; Min Wang; Huinan Zhang; Liang Li; Yikai Zhang; Jie Ge; Ying Song; Yuwen Li; Aidong Wen
Journal:  Mol Neurobiol       Date:  2015-07-11       Impact factor: 5.590

Review 7.  Advances in peripheral nerve regeneration.

Authors:  Jami Scheib; Ahmet Höke
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

8.  Efficient repairing effect of PEG based tri-block copolymer on mechanically damaged PC12 cells and isolated spinal cord.

Authors:  Iman Rad; Hamid Mobasheri; Farhood Najafi; Maryam Rezaei
Journal:  J Mater Sci Mater Med       Date:  2014-02-12       Impact factor: 3.896

Review 9.  Promising Role of Nano-Encapsulated Drugs for Spinal Cord Injury.

Authors:  Tasneem Ismail Khan; S Hemalatha; Mohammad Waseem
Journal:  Mol Neurobiol       Date:  2020-01-03       Impact factor: 5.590

Review 10.  Nanomedicine for treating spinal cord injury.

Authors:  Jacqueline Y Tyler; Xiao-Ming Xu; Ji-Xin Cheng
Journal:  Nanoscale       Date:  2013-08-14       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.